As of 2024-12-15, the Relative Valuation of Medincell SA (MEDCL.PA) is (12.61) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 16.30 EUR, the upside of Medincell SA based on Relative Valuation is -177.4%.
The range of the Relative Valuation is (12.76) - (11.90) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 13.9x | 13.6x |
| Forward P/E multiples | 14.9x - 16.8x | 15.8x |
| Fair Price | (12.76) - (11.90) | (12.61) |
| Upside | -178.3% - -173.0% | -177.4% |
| Date | P/E |
| 2024-12-13 | -19.04 |
| 2024-12-12 | -17.54 |
| 2024-12-11 | -18.12 |
| 2024-12-10 | -19.97 |
| 2024-12-09 | -19.60 |
| 2024-12-06 | -19.57 |
| 2024-12-05 | -19.53 |
| 2024-12-04 | -19.43 |
| 2024-12-03 | -19.34 |
| 2024-12-02 | -19.27 |
| 2024-11-29 | -21.16 |
| 2024-11-28 | -20.86 |
| 2024-11-27 | -21.14 |
| 2024-11-26 | -21.11 |
| 2024-11-25 | -20.67 |
| 2024-11-22 | -20.34 |
| 2024-11-21 | -20.04 |
| 2024-11-20 | -20.09 |
| 2024-11-19 | -19.85 |
| 2024-11-18 | -19.53 |
| 2024-11-15 | -20.39 |
| 2024-11-14 | -20.79 |
| 2024-11-13 | -20.90 |
| 2024-11-12 | -20.88 |
| 2024-11-11 | -21.49 |
| 2024-11-08 | -20.95 |
| 2024-11-07 | -20.55 |
| 2024-11-06 | -18.94 |
| 2024-11-05 | -17.87 |
| 2024-11-04 | -17.96 |
| 2024-11-01 | -17.80 |
| 2024-10-31 | -17.49 |
| 2024-10-30 | -17.87 |
| 2024-10-29 | -17.56 |
| 2024-10-28 | -17.35 |
| 2024-10-25 | -17.59 |
| 2024-10-24 | -17.52 |
| 2024-10-23 | -18.12 |
| 2024-10-22 | -18.43 |
| 2024-10-21 | -18.45 |
| 2024-10-18 | -18.26 |
| 2024-10-17 | -17.91 |
| 2024-10-16 | -17.91 |
| 2024-10-15 | -18.71 |
| 2024-10-14 | -18.31 |
| 2024-10-11 | -17.75 |
| 2024-10-10 | -17.52 |
| 2024-10-09 | -17.77 |
| 2024-10-08 | -17.87 |
| 2024-10-07 | -17.94 |